According to GlobalData’s medical device pipeline database, 40 Pacemakers devices are in various stages of development globally. GlobalData’s report Pacemakers provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 24 are in active development, while the remaining 17 are in an inactive stage of development. There are 11 products in the early stages of development, and the remaining 13 are in the late stages of development.
A pacemaker is a device designed to regulate the beating of the heart by providing electrical impulses delivered by the electrodes contacting the heart muscle. A pacemaker can be a single chamber or dual chamber type. One unit refers to One pacemaker.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Pacemakers pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Pacemakers devices. Overall, most of these Pacemakers pipeline devices are being developed by private entities.
Key players involved in the active development of Pacemakers include Medtronic, MicroPort CRM, Boston Scientific, Biotronik SE, University of Southern California, Abbott Vascular, Arizona State University, Boston TransTec, Cairdac and Duke University.
For a complete picture of the developmental pipeline for Pacemakers devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.